These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 6801201)

  • 1. Interactions of di-n-propylacetate, gabaculine, and aminooxyacetic acid: anticonvulsant activity and the gamma-aminobutyrate system.
    Wood JD; Kurylo E; Tsui SK
    J Neurochem; 1981 Dec; 37(6):1440-7. PubMed ID: 6801201
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The gamma-aminobutyrate content of nerve endings (synaptosomes) in mice after the intramuscular injection of gamma-aminobutyrate-elevating agents: a possible role in anticonvulsant activity.
    Wood JD; Russell MP; Kurylo E
    J Neurochem; 1980 Jul; 35(1):125-30. PubMed ID: 7452248
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vivo effects of aminooxyacetic acid and valproic acid on nerve terminal (synaptosomal) GABA levels in discrete brain areas of the rat. Correlation to pharmacological activities.
    Löscher W; Vetter M
    Biochem Pharmacol; 1985 May; 34(10):1747-56. PubMed ID: 3924047
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 3-Mercaptopropionic acid: convulsant properties, effects on enzymes of the gamma-aminobutyrate system in mouse brain and antagonism by certain anticonvulsant drugs, aminooxyacetic acid and gabaculine.
    Löscher W
    Biochem Pharmacol; 1979 Apr; 28(8):1397-407. PubMed ID: 444305
    [No Abstract]   [Full Text] [Related]  

  • 5. A dual mechanism for the anticonvulsant action of aminooxyacetic acid.
    Wood JD; Peesker SJ
    Can J Physiol Pharmacol; 1976 Aug; 54(4):534-40. PubMed ID: 974880
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The use of inhibitors of GABA-transaminase for the determination of GABA turnover in mouse brain regions: an evaluation of aminooxyacetic acid and gabaculine.
    Bernasconi R; Maitre L; Martin P; Raschdorf F
    J Neurochem; 1982 Jan; 38(1):57-66. PubMed ID: 7108535
    [No Abstract]   [Full Text] [Related]  

  • 7. Changes in the amino acid content of nerve endings (synaptosomes) induced by drugs that alter the metabolism of glutamate and gamma-aminobutyric acid.
    Geddes JW; Wood JD
    J Neurochem; 1984 Jan; 42(1):16-24. PubMed ID: 6139419
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of inhibitors of gamma-aminobutyric acid (GABA) transaminase for the estimation of GABA turnover in various brain regions of rats: a reevaluation of aminooxyacetic acid.
    Löscher W; Hönack D; Gramer M
    J Neurochem; 1989 Dec; 53(6):1737-50. PubMed ID: 2809589
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparative study of the pharmacology of inhibitors of GABA-metabolism.
    Löscher W
    Naunyn Schmiedebergs Arch Pharmacol; 1980; 315(2):119-28. PubMed ID: 6782493
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo effects of anticonvulsant drugs on nerve terminal (synaptosomal) GABA levels in 11 brain regions of the rat.
    Löscher W; Vetter M; Böhme G; Stoltenburg-Didinger G
    J Neural Transm; 1985; 63(2):157-67. PubMed ID: 3930660
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combined effects of a metabolic inhibitor (gabaculine) and an uptake inhibitor (ketamine) on the gamma-aminobutyrate system in mouse brain.
    Wood JD; Geddes JW; Tsui SK; Kurylo E
    J Neurochem; 1982 Dec; 39(6):1710-5. PubMed ID: 7142997
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship between gamma-aminobutyric acid metabolism and antivitamin B6-induced convulsions.
    Abe M
    J Nutr Sci Vitaminol (Tokyo); 1978; 24(4):419-27. PubMed ID: 712435
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gabapentin increases aminooxyacetic acid-induced GABA accumulation in several regions of rat brain.
    Löscher W; Hönack D; Taylor CP
    Neurosci Lett; 1991 Jul; 128(2):150-4. PubMed ID: 1945036
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aminooxyacetic acid induced accumulation of GABA in the rat brain. Interaction with GABA receptors and distribution in compartments.
    Pagliusi SR; Gomes C; Leite JR; Trolin G
    Naunyn Schmiedebergs Arch Pharmacol; 1983 Apr; 322(3):210-5. PubMed ID: 6306485
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drug-induced changes in GABA content of nerve endings in 11 rat brain regions. Correlation to pharmacological effects.
    Löscher W; Vetter M
    Neurosci Lett; 1984 Jun; 47(3):325-31. PubMed ID: 6089052
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of kindling-induced generalized seizures by aminooxyacetic acid.
    Le Gal La Salle G
    Can J Physiol Pharmacol; 1980 Jan; 58(1):7-11. PubMed ID: 7378907
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Amino acid content of nerve endings (synaptosomes) in different regions of brain: effects of gabaculine and isonicotinic acid hydrazide.
    Wood JD; Kurylo E
    J Neurochem; 1984 Feb; 42(2):420-5. PubMed ID: 6693878
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Valproate enhances GABA turnover in the substantia nigra.
    Löscher W
    Brain Res; 1989 Oct; 501(1):198-203. PubMed ID: 2508993
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of tolerance to the anticonvulsant effect of GABAmimetic drugs in genetically epilepsy-prone gerbils.
    Löscher W
    Pharmacol Biochem Behav; 1986 Apr; 24(4):1007-13. PubMed ID: 3086900
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of drugs on rat brain, cerebrospinal fluid and blood GABA content.
    Ferkany JW; Butler IJ; Enna SJ
    J Neurochem; 1979 Jul; 33(1):29-33. PubMed ID: 379280
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.